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Scientific Abstracts patients scoring ≤10mm (16.1%), corresponding to a difference of up to 4.7% versus other PGAs. Similar results were found for the ≤20 cut-off (Table 1) . By using different PGA's formulations the rates of remission calculated with different indices can vary between 4.7% and 6.7% (Table 2) . Bland-Altman chart confirmed the low agreement between ACR/EULAR formulation and the other PGA formulations (p<.05), except for the DAS "general health" (p=.054). 1 Quality of life (Qol) in patients with RA may be substantially impacted by their inability to perform daily activities, a shift in family roles, more restricted employment opportunities, increased financial burden and social dependency and reduced recreational activities. Objectives: To investigate the Qol among RA patients and its association with demographic and socioeconomic details. Methods: This is a cross-sectional study conducted in a rheumatology outpatient clinic in Malaysia. Patients who fulfilled 2010 ACR/ EULAR classification criteria for RA were asked to answer WHOQOL-BREF questionnaire and specific questions on demographics and socio-economic details, during their attendance to rheumatology clinics. WHOQOL-BREF is a self-report quality of life questionnaire on individual's perception of quality of life and health, physical health, psychological, social relationships and environment domains. Data was analysed using SPSS 20. Student's t-test was used to analyse the mean difference between two groups and chi-square test was used to analyse between 2 categorical data. Pearson correlation was used to analyse correlation between two groups of continuous data. p<0.05 was considered significant. Results: The mean age of patients in this study was 53.10 (±14.3) years, with majority being females (80.4%) and married (70.6%). Half of the patients were Malays (49.0%). 51.0% rated overall quality of life as good and 41.2% rated overall health as satisfied. The mean transformed scores were 55.2 (±15.9) in physical health, 57.3 (±15.9) in psychological, 59.2 (±18.1) in social relationships and 58.2 (±15.2) in environment domains. There were significant differences in the transformed scores for Malay (65.5±15.9) and non-Malay (53.1±18.2) in the social relationship domain; t (49) =2.58, p=0.01, and for education at secondary level and above (65.9±14.9) and primary level (48.0±16.6), t(49)=-3.87, p<0.01. We found no significant association between race and education level; 17 (53.1%) Malays and 15 (46.9%) non-Malays had education level of secondary and higher, X 2 (1, N=51) =0.58, p=0.48. Patients with household income of less than RM 3, 000 had significantly lower scores compared to those with higher household income, in overall perception of quality of life (3.3±0.9 vs 4.0±0.6; t(49)=-2.8, p<0.01), overall perception of health (2.9±0.9 vs 3.6±0.7, t(49)=-2.97, p<0.01), physical health domain (51.2±16.2 vs 63.8±11.6, t(49)=-2.78, p=0.01) and psychological domain (53.3±16.3 vs 66.1±10.9, t(49)=-2.85, p=0.01). Conclusions: Patients with RA perceived their Qol to be moderate in all domains. Social relationship was perceived to be better in Malays and patients with higher educational level. Low income was significantly associated lower overall quality of life and health, physical and psychological health. Results: Among 1229 patients (78.8% female), mean age was 53.3±12.9 and disease duration was 11.4±7.9. Thorax CT had been performed in 203 (16.5%) patients. Distribution of pathologic findings in thorax CT was represented in Table  1 . 29 patients (%2.4) were diagnosed as ILD with regard to CT findings. Patients with ILD were older (64.5±6.7 vs 60.6±10.1, p=0.039) and more frequently positive for rheumatoid factor (RF) (25/27 (%92.6) vs 77/121 (%63.3), p=0.003) than patients without ILD. ILD was detected before beginning of biologics in 11 (37.9%) patients and during biologic treatment in 18 (62.1%) patients. Honeycombing was seen in 10 (34.5%) patients. First choice of biologic agent was RTX in 10 (34.5%) and TNFi in 19 (65.5%) patients. In ILD patients, mean follow-up duration was 51±31 months and first biologic was switched to another in 16 (55.2%) of patients. At the last follow-up visit 19 (65.5%) patients were on rituximab, 3 (10.3%) patients were on abatacept and 7 (24.1%) were on TNFi. Small airway disease was detected in 19 (9.3%) patients. History of smoking was present in only 4 (21.0%) of patients with small airway disease. 
